Sato, T
Goyama, S
Kataoka, K
Nasu, R
Tsuruta-Kishino, T
Kagoya, Y
Nukina, A
Kumagai, K
Kubota, N
Nakagawa, M
Arai, S
Yoshimi, A
Honda, H
Kadowaki, T
Kurokawa, M
Article History
Received: 10 November 2013
Revised: 17 February 2014
Accepted: 12 March 2014
First Online: 21 April 2014
Competing interests
: MK is a member of the advisory committees of Bristol-Myers and Novartis, and has also received research funding and honoraria from the two companies. The remaining authors declare no conflict of interest.